KPIs & Operating Metrics(New)
Growth Metrics

Teva Pharmaceutical Industries (TEVA) Goodwill & Intangibles (2016 - 2026)

Teva Pharmaceutical Industries filings provide 18 years of Goodwill & Intangibles readings, the most recent being $19.4 billion for Q1 2026.

  • On a quarterly basis, Goodwill & Intangibles fell 1.19% to $19.4 billion in Q1 2026 year-over-year; TTM through Mar 2026 was $19.4 billion, a 1.19% decrease, with the full-year FY2025 number at $19.8 billion, down 3.12% from a year prior.
  • Goodwill & Intangibles hit $19.4 billion in Q1 2026 for Teva Pharmaceutical Industries, down from $19.8 billion in the prior quarter.
  • In the past five years, Goodwill & Intangibles ranged from a high of $27.1 billion in Q1 2022 to a low of $7.2 billion in Q2 2022.
  • Median Goodwill & Intangibles over the past 5 years was $21.3 billion (2024), compared with a mean of $21.0 billion.
  • Biggest five-year swings in Goodwill & Intangibles: tumbled 74.85% in 2022 and later skyrocketed 218.37% in 2023.
  • Teva Pharmaceutical Industries' Goodwill & Intangibles stood at $23.4 billion in 2022, then fell by 3.77% to $22.6 billion in 2023, then decreased by 9.51% to $20.4 billion in 2024, then decreased by 3.12% to $19.8 billion in 2025, then dropped by 1.77% to $19.4 billion in 2026.
  • The last three reported values for Goodwill & Intangibles were $19.4 billion (Q1 2026), $19.8 billion (Q4 2025), and $19.9 billion (Q3 2025) per Business Quant data.